ClearPoint Neuro (Nasdaq:CLPT) announced today that it is developing a proprietary robotic neuro-navigation system. The Solana Beach, California-based company says its new product category can enable its navigation software to operate the Kuka LBR robotic arm, supporting all minimally invasive cranial surgical procedures. Those include cell and gene therapy infusions, laser catheter placement, biopsy workflows […]
ClearPoint Neuro
ClearPoint Neuro enters drug delivery licensing deal with UCB
ClearPoint Neuro (Nasdaq:CLPT) announced today that it entered into a multi-year license agreement with UCB over gene therapy delivery. Solana Beach, California-based ClearPoint Neuro develops a therapy-enabling platform providing navigation and delivery to the brain. The licensing agreement with UCB establishes a partnership on delivery platforms for UCB’s gene therapy portfolio. “We are extremely excited […]
